Nextgen Healthcare (NASDAQ:NXGN) issued its earnings results on Thursday. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.04 by $0.17, MarketWatch Earnings reports. The business had revenue of $130.88 million for the quarter, compared to analyst estimates of $115.11 million. Nextgen Healthcare had a net margin of 1.01% and a return on equity of 10.64%.
Shares of NXGN traded up $2.08 during trading hours on Friday, hitting $14.62. The company’s stock had a trading volume of 1,035,280 shares, compared to its average volume of 254,836. The company has a market cap of $975.34 million, a price-to-earnings ratio of 162.44, a PEG ratio of 5.85 and a beta of 0.99. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.82 and a quick ratio of 1.82. The business has a 50 day simple moving average of $10.96 and a two-hundred day simple moving average of $11.42. Nextgen Healthcare has a 52-week low of $5.10 and a 52-week high of $18.49.
NXGN has been the topic of several research analyst reports. Piper Sandler increased their target price on shares of Nextgen Healthcare from $17.00 to $23.00 and gave the stock an “overweight” rating in a research note on Friday. Robert W. Baird lowered their target price on shares of Nextgen Healthcare from $16.00 to $12.00 and set a “neutral” rating for the company in a report on Thursday, May 7th. Royal Bank of Canada assumed coverage on shares of Nextgen Healthcare in a report on Monday, April 20th. They set a “sector perform” rating and a $11.00 price objective for the company. Jefferies Financial Group decreased their price objective on shares of Nextgen Healthcare from $14.00 to $11.50 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Finally, Wells Fargo & Co restated a “hold” rating on shares of Nextgen Healthcare in a report on Friday. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $12.46.
About Nextgen Healthcare
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Featured Story: How Do Mutual Funds Work?
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.